Related Experiment Videos
ASO Visual Abstract: Risk-adapted use of adjuvant systemic therapy after nephrectomy for renal cell carcinoma: a
Maximilian Filzmayer1,2, Michele Petix3,4,5, Leonardo Quarta3,6,7
1Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, QC, Canada. filzmayer@med.uni-frankfurt.de.
Annals of Surgical Oncology
|August 10, 2026
Abstract
No abstract available in PubMed .